You are not entirely correct. quote" Mesoblast’s licensee in Japan, JCR Pharmaceuticals Co. Ltd., is marketing its mesenchymal stem cell-based product for the treatment of this disease in children and adults. TEMCELL® HS Inj. was the first allogeneic cellular medicine to receive full approval in Japan."
You are not entirely correct. quote" Mesoblast’s licensee in...
-
- There are more pages in this discussion • 118 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
21.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $34.32M | |||
| Open | High | Low | Value | Volume |
| 21.5¢ | 21.5¢ | 21.5¢ | $5.375K | 25K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 27580 | 21.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.0¢ | 41728 | 1 |
View Market Depth
| Last trade - 12.20pm 29/11/2024 (20 minute delay) ? |
| CYP (ASX) Chart |
